Download now to learn how to navigate risk and maintain quality for SIs throughout
fill-finish
Sterile injectable (SI) medicines continue to transform the treatment landscape,
particularly for therapeutic areas such as chronic disease and oncology. However, as
these therapies become increasingly complex and patient-centric, they inherently
introduce new challenges for manufacturing. Consequently, the regulatory demands on
aseptic fill-finish operations have never been higher.
In this eBook, Pfizer experts explore how regulatory expertise and rigorous processes
come together to help ensure that complex SI therapies are delivered safely, efficiently
and at scale.